Should therapeutic hypothermia be offered to babies with mild neonatal encephalopathy in the first 6 h after birth? by El-Dib, Mohamed et al.
                          El-Dib, M., Inder, T. E., Chalak, L. F., Thoresen, M., & Gunn, A. J. (2019).
Should therapeutic hypothermia be offered to babies with mild neonatal
encephalopathy in the first 6h after birth? Pediatric Research, 85, 442-448.
https://doi.org/10.1038/s41390-019-0291-1
Peer reviewed version
License (if available):
Other
Link to published version (if available):
10.1038/s41390-019-0291-1
Link to publication record in Explore Bristol Research
PDF-document
This is the accepted author manuscript (AAM). The final published version (version of record) is available online
via Springer Nature at https://doi.org/10.1038/s41390-019-0291-1 . Please refer to any applicable terms of use
of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Why results from Bayesian statistical analyses of clinical trials with a strong prior and small sample 
sizes may be misleading.  
The case of the NICHD Neonatal Research Network Late Hypothermia Trial 
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We would like to thank Laptook et al. for their response (1) to our "Major concerns about late 
hypothermia study" (2). However, their response suggests that the difference between their opinion 
and ours arises because we are using frequentist statistics and they are using Bayesian. This is not the 
case. There is indeed general concern at present about the potential misuse of p-values in 
frequentist statistical practice. We agree that generally in situations where a limited number of 
observations is available, the usual frequentist requirement for the significance probability to be 
lower than 0.05 is too strict. Results with a significance probability of 0.10 or even 0.15 may also give 
valuable information, and correspondingly a confidence interval (frequentist) or credibility interval 
(Bayesian) of 0.95 is sometimes too strict.   
 
The heart of the matter is whether the observation that 19 of 78 neonates in group 1 (with cooling 
initiated in the time window from 6 hr to 24 hr after birth) showed adverse outcomes can be said to 
indicate that the associated probability p1 is smaller than the corresponding probability p0 in the 
control group, where 22 of 79 showed adverse outcomes. The original JAMA paper (3) discussed this 
in terms of the relative risk rr = p1/p0, and the question is whether there are any grounds to claim, 
with any meaningful confidence or credibility (to use the relevant frequentist and Bayesian terms), 
that rr is smaller than 1.  
 
Our primary analysis was indeed frequentist, demonstrating that with sample sizes 79 and 78 there 
can be no meaninful statistical difference between the probability estimates 19/78 = 0.244 and 
22/79 = 0.278. The close proximity of these two estimates can be assessed in several ways, including 
a p-value far above the customary levels for significance (p = 0.75), and a confidence curve with the 
value rr = 1 in the middle with a 95 percent confidence interval [0.51, 1.48] (figure). 
 
We have nothing against Bayesian analyses in general, and we agree that Laptook et al.'s “neutral” 
unimodal prior with rr = 1 is sensible if no prior knowledge on late cooling is available. The detailed 
shape and especially the tails of this prior probability distribution are of course rather uncertain. As 
our figure clearly show, Laptook et al’s results give little support for the claim that p1 is smaller than 
p0 (i.e. that the relative risk parameter rr = p1/p0 above is smaller than 1). We have also performed a 
sensitivity analysis on the results of the trial. We moved two infants from the control group to the 
cooled group, so that the outcome was death or disability for 21 of 78 infants in the cooled group 
and 20 of 79 in the control group.  These results would indicate a slightly better outcome for the 
control group, which is certainly possible if there is no real difference between the two groups. 
 
The figure displays Laptook et al.'s Bayesian prior probability distribution (in red) and two posterior 
probability distributions (in black) for the rr parameter. The solid black curve is the posterior using 
the observed data, while the dashed black curve is the posterior using the hypothetical outcomes 
from the sensitivity analysis. The 95 percent credibility intervals for rr are [0.61, 1.40] and [0.68, 
1.58], respectively, for the two posterior distributions. rr = 1.00 is close to the middle (median) in all 
three cases. Even intervals with 70% credibility or less would cover rr = 1.00 in all three distributions, 
indicating that there is no real difference between the two groups. 
 
In the JAMA paper Laptook et al write “The probability that death or disability in cooled infants was 
at least 1%, 2%, or 3% less than noncooled infants was 71%, 64%, and 56%, respectively”, and 
further: cooling “compared with noncooling resulted in a 76% probability of any reduction in death 
or disability” (3). Unfortunately, we have not been able to reproduce these numbers using Laptook et 
al’s “neutral” prior. According to our Bayesian calculations, the probability that death or disability in 
cooled infants was at least 1%, 2%, or 3% less than in non-cooled infants was 64%, 62%, and 60%, 
respectively, and cooling resulted in a 65% probability of any reduction in death or disability. Using 
the posterior distribution from the sensitivity analysis, the probabilities were 41%, 39%, 37%, and 
43%, respectively. Two observations can be made from these numbers. There is always a positive 
probability that death and disability in cooled infants is less than in non-cooled infants, even when 
the trial results indicate the opposite, but these probabilities vary greatly with small changes in the 
real outcome. We also see that the two posterior distributions are not very different from the prior 
distribution. In fact, they are heavily influenced by the prior and only to a limited degree by the 
results from the trial.  The probabilities in the tails of the posterior distribution are also strongly 
influenced by the shape and width of the prior distribution, of which we have limited knowledge. The 
very uncertain tail probabilities in the posterior distribution should therefore definitely not be used 
as arguments for late cooling.    
 
If the times when the cooling started had been given for all infants, other relevant statistical analyses 
could have been performed (e.g. logistic regression with time as a covariate or a Bayesian analysis 
with the results from late cooling of rat pups and foetal sheep as basis for a prior (2)). Although only 
tested in rats, one study showed that very severe injury   increased more  if cooling started 12 hr 
after the experimental insult (4). The current patient cohorts undergoing therapeutic hypothermia, 
including that in Laptook et al’s “Late hypothermia trial” (3) are all milder than  the original  trial 
cohorts  that showed that therapeutic hypothermia was effective. As an example; in the 2005 NICHD  
whole Body Cooling trial, the non-cooled group had 37% mortality and 40% disability in survivors (5). 
In the late hypothermia trial, the mortality in the non-cooled group was 11%, and 19% of the 
survivors had disabilities (3). We do not agree that there is evidence for suggesting starting 
hypothermia treatment late. Also, one does not know how high the risk for harm would be (6) if one 
expose rather mild HIE infants to 3 days of cooling and intensive care.  
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